ArticleCancers2022

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's Syndrome.

Benjamin M Heyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.